Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab
Magazine: Clinical and Translational Oncology
Date: Feb 1, 2007Radiation Oncology Medical Oncology
We report here a taxol–bevacizumab-responsive metastatic melanoma case.
Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained.
CITATION Clin Transl Oncol. 2007 Feb;9(2):119-20
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.